113
Views
0
CrossRef citations to date
0
Altmetric
Review

Predictive Relevance of ncRNAs in Non-Small-Cell Lung Cancer Patients with Radiotherapy: A Review of the Published Data

Pages 1149-1159 | Received 05 Jan 2018, Accepted 14 Jun 2018, Published online: 07 Sep 2018

References

  • Lindblom E , DasuA, Toma-DasuI. Optimal fractionation in radiotherapy for non-small-cell lung cancer: a modeling approach. Acta Oncol.54(9), 1592–1598 (2015).
  • Gordon JJ , SnyderK, ZhongHet al. Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance. Phys. Med. Biol.60(17), 6719–6732 (2015).
  • Graves PR , SiddiquiF, AnscherMS, MovsasB. Radiation pulmonary toxicity: from mechanisms to management. Semin. Radiat. Oncol.20(3), 201–207 (2010).
  • Guckenberger M , AllgauerM, AppoldSet al. Safety and efficacy of stereotactic body radiotherapy for stage I non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J. Thorac. Oncol.8(8), 1050–1058 (2013).
  • Kwint M , UyterlindeW, NijkampJet al. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy. Int. J. Radiat. Oncol. Biol. Phys.84(2), e223–e228 (2012).
  • Han S , GuF, LinGet al. Analysis of clinical and dosimetric factors influencing radiation-induced lung injury in patients with lung cancer. J. Cancer6(11), 1172–1178 (2015).
  • Giuliani ME , LindsayPE, KwanJYet al. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma. Clin. Lung Cancer16(3), 216–220 (2015).
  • Briere TM , KrafftS, LiaoZ, MartelMK. Lung size and the risk of radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys.94(2), 377–384 (2016).
  • Okubo M , ItonagaT, SaitoTet al. Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumors. Br. J. Radiol.90(1073 ), 20160508 ( 2017).
  • Baccarelli A , BollatiV. Epigenetics and environmental chemicals. Curr. Opin. Pediatr.21(2), 243–251 (2009).
  • Alegría-Torres JA , BaccarelliA, BollatiV. Epigenetics and lifestyle. Epigenomics3(3), 267–277 (2011).
  • Braicu C , TomuleasaC, MonroigP, CucuianuA, Berindan-NeagoeI, CalinGA. Exosomes as divine messengers: are they the hermes of modern molecular oncology?Cell Death Differ.22(1), 34–45 (2015).
  • Takahashi RU , Prieto-VilaM, HironakaA, OchiyaT. The role of extracellular vesicle microRNAs in cancer biology. Clin. Chem. Lab. Med.55(5), 648–656 (2017 ).
  • Moran VA , PereraRJ, KhalilAM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res.40(14), 6391–6400 (2012).
  • Bhan A , SoleimaniM, MandalSS. Long noncoding RNA and cancer: a new paradigm. Cancer Res.77(15), 3965–3981 (2017 ).
  • Klingenberg M , MatsudaA, DiederichsS, PatelT. Noncoding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J. Hepatol.67(3), 603–618 (2017).
  • Bolha L , Ravnik-GlavačM, GlavačD. Long noncoding RNAs as biomarkers in cancer. Dis. Markers 2017, 7243968 ( 2017).
  • Tian H , ZhouC, YangJ, LiJ, GongZ. Long and short noncoding RNAs in lung cancer precision medicine: opportunities and challenges. Tumour Biol.39(4 ), 1010428317697578 ( 2017).
  • Zhou Z , ZhaoY, GuL, NiuX, LuS. Inhibiting proliferation and migration of lung cancer using small-interfering RNA targeting on Aldoketo reductase family 1 member B10. Mol. Med. Rep.17(2), 2153–2160 (2018).
  • Zhao J , LiL, WangQ, HanH, ZhanQ, XuM. CircRNA expression profile in early stage lung adenocarcinoma patients. Cell. Physiol. Biochem.44(6), 2138–2146 (2017).
  • Zhu X , WangX, WeiSet al. hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J.284(14), 2170–2182 (2017).
  • Jin X , GuanY, ShengH, LiuY. Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer. Oncotarget8(53), 91270–91280 (2017).
  • He J , FengX, HuaJet al. miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells. Cell Cycle16(20), 1943–1953 (2017).
  • Guo Y , SunW, GongTet al. miR-30a radiosensitizes non-small-cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol. Rep.37(4), 1980–1988 (2017).
  • Cortez MA , ValdecanasD, NiknamSet al. In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Mol. Ther. Nucleic Acids4, e270 ( 2015).
  • Shin S , ChaHJ, LeeEMet al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small-cell lung cancer cells. Int. J. Oncol.35(1), 81–86 (2009).
  • Zhang A , XuM, MoYY. Role of the lncRNA-p53 regulatory network in cancer. J. Mol. Cell Biol.6(3), 181–191 (2014).
  • Chen JX , ChenM, ZhengYD, WangSY, ShenZP. Upregulation of BRAF activated noncoding RNA is associated with radiation therapy for lung cancer. Biomed. Pharmacother.71, 79–83 (2015).
  • Wang M , MengB, LiuY, YuJ, ChenQ, LiuY. MiR-124 inhibits growth and enhances radiation-induced apoptosis in non-small-cell lung cancer by inhibiting STAT3. Cell. Physiol. Biochem.44(5), 2017–2028 (2017).
  • Jiang LP , HeCY, ZhuZT. Role of microRNA-21 in radiosensitivity in non-small-cell lung cancer cells by targeting PDCD4 gene. Oncotarget8(14), 23675–23689 (2017).
  • Ma Y , XiaH, LiuY, LiM. Silencing miR-21 sensitizes non-small-cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt. Biomed. Res. Int. 2014, 617868 ( 2014).
  • Jiang S , WangR, YanH, JinL, DouX, ChenD. MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α -promoted glycolysis in non-small-cell lung cancer cells. Mol. Med. Rep.13(5), 4101–4107 (2016).
  • Zhu RX , SongCH, YangJS, YiQT, LiBJ, LiuSH. Downregulation of AATK mediates microRNA-558-induced resistance of A549 cells to radiotherapy. Mol. Med. Rep.14(3), 2846–2852 (2016).
  • Tang Y , CuiY, LiZet al. Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. J. Exp. Clin. Cancer. Res.35, 7 ( 2015).
  • Ma D , JiaH, QinMet al. MiR-122 induces radiosensitization in non-small-cell lung cancer cell line. Int. J. Mol. Sci.16(9), 22137–22150 (2015).
  • He Z , LiuY, XiaoB, QianX. MiR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression. Biochem. Biophys. Res. Commun.457(3), 235–241 (2015).
  • Lan F , YueX, RenGet al. miR-15a/16 enhances radiation sensitivity of non-small-cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway. Int. J. Radiat. Oncol. Biol. Phys.91(1), 73–81 (2015 ).
  • Yang H , TangY, GuoWet al. Upregulation of microRNA-138 induce radiosensitization in lung cancer cells. Tumour Biol.35(7), 6557–6565 (2014).
  • Zhang HH , PangM, DongWet al. miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX. Oncol. Rep.31(3), 1473–1479 (2014).
  • Liu YJ , LinYF, ChenYFet al. MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. PLoS ONE8(4), e62383 ( 2013).
  • Chen J , ShenZ, ZhengY, WangS, MaoW. Radiotherapy induced Lewis lung cancer cell apoptosis via inactivating β-catenin mediated by upregulated HOTAIR. Int. J. Clin. Exp. Pathol.8(7), 7878–7886 (2015).
  • Grosso S , DoyenJ, ParksSKet al. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis.4, e544 ( 2013).
  • Ikezawa Y , Sakakibara-KonishiJ, MizugakiH, OizumiS, NishimuraM. Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch-expressing lung cancer. Int. J. Clin. Oncol.22(1), 59–69 (2017).
  • Xu YM , LiaoXY, ChenXW, LiDZ, SunJG, LiaoRX. Regulation of miRNAs affects radiobiological response of lung cancer stem cells. Biomed. Res. Int. 2015, 851841 ( 2015 ).
  • Duru N , GernapudiR, ZhangYet al. NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts. Cancer. Lett.369(1), 184–191 (2015).
  • Rahman M , LovatF, RomanoGet al. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung. J. Biol. Chem.289(38), 26406–26416 (2014).
  • Kabacik S , ManningG, RaffyC, BoufflerS, BadieC. Time, dose and ataxia telangiectasia mutated (ATM) status dependency of coding and noncoding RNA expression after ionizing radiation exposure. Radiat. Res.183(3), 325–337 (2015).
  • Nie J , PengC, PeiWet al. A novel role of long noncoding RNAs in response to x-ray irradiation. Toxicol. In Vitro30(1 Pt B), 536–544 (2015).
  • Jiang Y , ChenX, TianW, YinX, WangJ, YangH. The role of TGF-β1-miR-21-ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells. Br. J. Cancer.111(4), 772–780 (2014).
  • Kwon OS , KimKT, LeeEet al. Induction of miR-21 by stereotactic body radiotherapy contributes to the pulmonary fibrotic response. PLoS ONE11(5), e0154942 ( 2016).
  • Kim YW , ByzovaTV. Oxidative stress in angiogenesis and vascular disease. Blood123(5), 625–631 (2014).
  • Song Y , ZuoY, QianXLet al. Inhibition of microRNA-21-5p promotes the radiation sensitivity of non-small cell lung cancer through HMSH2. Cell. Physiol. Biochem.43(3), 1258–1272 (2017).
  • Wang XC , WangW, ZhangZB, ZhaoJ, TanXG, LuoJC. Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat. Oncol.8, 146 ( 2013).
  • Shen Z , WuX, WangZ, LiB, ZhuX. Effect of miR-18a over- expression on the radiosensitivity of non-small-cell lung cancer. Int. J. Clin. Exp. Pathol.8(1), 643–648 (2015).
  • Yin J , ZhaoJ, HuWet al. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo- resistance in non-small-cell lung cancer. PloS ONE12(2), e0172787 ( 2017).
  • Ma W , MaCN, LiXD, ZhangYJ. Examining the effect of gene re-duction in miR-95 and enhanced radiosensitivity in non-small-cell lung cancer. Cancer. Gene. Ther.23(2-3), 66–71 (2016).
  • Wang R , YeF, ZhenQet al. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer. J. Physiol. Biochem.72(2), 337–343 (2016).
  • Wang XC , DuLQ, TianLLet al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small-cell lung cancer. Lung Cancer72(1), 92–99 (2011).
  • Ma W , MaCN, ZhouNN, LiXD, ZhangYJ. Upregulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy. Sci. Rep.6, 31651 ( 2016).
  • Wu D , LiY, ZhangH, HuX. Knockdown of lncrna PVT1 enhances radiosensitivity in non-small-cell lung cancer by sponging mir-195. Cell. Physiol. Biochem.42(6), 2453–2466 (2017).
  • Xue Y , NiT, JiangY, LiY. Long noncoding RNA GAS5 inhibits tumorigenesis and enhances radiosensitivity by suppressing miR-135b expression in non-small-cell lung cancer. Oncol. Res.25(8), 1305–1316 (2017).
  • Chen X , XuY, LiaoXet al. Plasma miRNAs in predicting radiosensitivity in non-small-cell lung cancer. Tumour. Biol.37(9), 11927–11936 (2016).
  • Sun Y , HawkinsPG, BiNet al. Serum microRNA signature predicts response to high-dose radiation therapy in locally advanced non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys.100(1), 107–114 (2018 ).
  • Xu T , LiaoZ, O'ReillyMSet al. Serum inflam- matory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small-cell lung cancer. Radiother. Onco.113(3), 379–384 (2014 ).
  • Dinh TK , FendlerW, Chałubińska-FendlerJet al. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small-cell lung cancer. Radiat. Oncol.11, 61 ( 2016 ).
  • Dai X , FangM, LiS, YanY, ZhongY, DuB. miR-21 is involved in transforming growth factor β1-induced chemoresistance and invasion by targeting PTEN in breast cancer. Oncol. Lett.14(6), 6929–6936 (2017).
  • Wu Y , SongY, XiongYet al. MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer. Cell. Physiol. Biochem.43(3), 945–958 (2017).
  • Zhou Y , ShengB, XiaQ, GuanX, ZhangY. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small-cell lung cancer. Cancer. Gene. Ther.24(8), 317–324 (2017).
  • Li R , PuX, ChangJYet al. MiRNA-related genetic variations associated with radiotherapy-induced toxicities in patients with locally advanced non-small-cell lung cancer. PLoS ONE11(3), e0150467 (2016).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.